glp-1 benefits and risks A Balancing Act: Weighing the of GLP-1s Unlocking the broad health benefits

Annu Rev Physiol 62:621647 Arbogast LA, Voogt JL (1996) The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat

Novo Nordisk asks FDA not to allow GLP-1 compounding Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs

Common triggers include changes in routines, separation anxiety, and too much or too little exercise

One study found that, among patients taking thyroid medication, only 60% were within the normal hormone range

It does not slow the disease down